Overall, our results show that CD38 and HLA-DR co-expression on Mtb-specific T-cells has good performance characteristics for active TB regardless of HIV status and has potential for early treatment monitoring in HIV+TB individuals on ART. This evidence concerns the gene CD38 and tuberculosis.